Last reviewed · How we verify

NCT04255927

Triclosan-antibacterial Sutures Impact on the Incidence of Surgical Site Infection in Laparoscopic Surgeries.

Completed Phase 4 Last updated 11 May 2022
What this trial tests

Phase 4 trial testing Coated Vicryl plus in Laparoscopic Surgery in 912 participants. Completed in 20 April 2022.

Timeline
5 February 2020
Primary endpoint
10 March 2022
20 April 2022

Quick facts

Lead sponsorClinAmygate
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment912
Start date5 February 2020
Primary completion10 March 2022
Estimated completion20 April 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

ClinAmygate — full company profile →

Who can join

Adults 18 to 75, any sex, with Laparoscopic Surgery or Surgical Wound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparing the incidence of PSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in laparoscopic sleeve gastrectomy, laparoscopic appendectomy or laparoscopic cholecystectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Laparoscopic Surgery

Currently open trials in the same condition.

Other ClinAmygate trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04255927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing